Vitamin D, sunlight and longevity

Minerva Endocrinologica

Volumn 36, Issue 3, 2011, Pages 257-266

  Perez Lopez F R ^a   Fernandez Alonso A M ^b   Mannella, P ^c   Chedraui, P ^d  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL TORRECÁRDENAS   (Spain)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

Author keywords

Cancer; Longevity; Mortality; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D;

CARDIOVASCULAR DISEASE; HUMAN; HYDROXYLATION; INFECTION; LONGEVITY; NEOPLASM; OUTCOME ASSESSMENT; PHOTOSYNTHESIS; REVIEW; SUNLIGHT; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

BONE DENSITY CONSERVATION AGENTS; DIET; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; LONGEVITY; RISK ASSESSMENT; RISK FACTORS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY; WORLD HEALTH;

EID: 84255183214     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Amanatullah DF, Zafonte BT, Pestell RG. The cell cycle in steroid hormone regulated proliferation and differentiation. Minerva Endocrinol 2002;27:7-20.
2. Pérez-López FR. Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol 2007;23:13-24.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
4. Pérez-López FR, Chedraui P, Fernández-Alonso AM. Vitamin D and aging: beyond calcium and bone metabolism. Maturitas 2011;69:27-36.
5. Mattila P, Lampi A-M, Ronkainen R, Toivo J, Piironen. Sterol and vitamin D2 contents in some wild and cultivated mushrooms. Food Chemistry 2002;76:293-8. (Pubitemid 34097742)
6. 2 concentrations in cultivated and wild grown mushrooms: Effects of UV irradiation. LWT - Food Science and Technology 2007;40:815-22.
7. Flynn A, Hirvonen T, Mensink GBM, Ocké MC, Serra-Majem L, Stos K et al. Intake of selected nutrients from foods, from fortification and from supplements in various European countries. Food Nutr Res 2009;53. doi: 10.3402/fnr.v53i0.2038.
8. Stumpf WE. Vitamin D soltriol the heliogenic steroid hormone: somatotrophic activator and modulator. Discoveries from histochemical studies lead to new concepts. Histochemistry 1988;89:209-19.
9. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 2011;11:325-35.
10. Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009;64:67-79.
11. Hausman DB, Fischer JG, Johnson MA. Nutrition in centenarians. Maturitas 2011;68:203-9.
12. Bischoff-Ferrari HA. The 25-hydroxyvitamin D threshold for better health. J Steroid Biochem Mol Biol 2007;103:614-9. (Pubitemid 46401308)
13. Pérez-López FR. Vitamin D and adolescent health. Adolescent Health, Medicine and Therapeutics 2010;1:1-8.
14. Pérez-López FR, Fernández-Alonso AM, Ferrando-Marco P, González-Salmerón MD, Dionis-Sánchez EC, Fiol-Ruiz G et al. First trimester serum 25-hydroxy-vitamin D status and factors related to lower levels in gravids living in the Spanish Mediterranean coast. Reprod Sci 2011;18:730-6.
15. Ford ES, Zhao G, Tsai J, Li C. Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int J Epidemiol 2011;40:998-1005.
16. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 2010;8:11-8.
17. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR et at. Relationship of 25-hydroxy-vitamin D with all-cause and cardiovascular disease mortality in older community- dwelling adults. Eur J Clin Nutr 2010;64:203-9.
18. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol 2010;162.935-42.
19. Kilkkinen A, Knekt P, Aro A, Charles I, Fairweather N, Tite J et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009;170:1032-9.
20. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older popu- lation in Finland. Eur J Nutr 2011;50:305-12.
21. Michaëlsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundström J et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010;92:841-8.
22. Joergensen C, Gall MA, Schmedes A, Tarnow L, Pairing HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010;33:2238-43.
23. Schierbeck LL, Jensen TS, Bang U, Jensen G, Køber L, Jensen JE. Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 2011;13:626-32.
24. Braun A, Chang D, Mahadevappa K, Gibbons FK, Liu Y, Giovannucci E et al. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med 2011;39:671-7.
25. Annweiler C, Pochic S, Fantino B, Legrand E, Bataille R, Montero-Odasso M et al. Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings. Adv Ther 2010;27:245-9.
26. Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008;24:139-49. (Pubitemid 351160247)
27. Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010;16:1-9.
28. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin d status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011;20:1003-16.
29. Risio M, Venesio T, Kolomoets E, Armaroli P, Gallo F, Balsamo A et al.; BECaP Working Group. Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers. Cancer Epidemiol 2011;35:18-24].
30. Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z et al. Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell 2010;17:273-85.
31. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61. (Pubitemid 43167123)
32. Garland CF, Gorham ED, Baggerly CA, Garland FC. Re: prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2008;100:826-7. (Pubitemid 351809664)
33. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128:1414-24.
34. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K et al. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 2011;6:e18625.
35. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelonet F. Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N Cohort. Cancer Epidemiol Biomarkers Prev 2011;20:187-98.
36. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum vitamin D and cancer mortality in the NHANES III Study (1988-2006). Cancer Res 2010;70:8587-97.
37. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 2011;4:735-43.
38. Yamshchikov AV, Desai MS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009;15:438-49.
39. Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997;349:1801-4. (Pubitemid 27257557)
40. Martineau AR, Wilkinson RJ. Wilkinson KA, Newton SM, Kampmann B, Hall BM et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Resp Crit Care Med 2007;176:208-13. (Pubitemid 47057859)
41. Banajeh SM. Nutritional rickets and vitamin D deficiency - association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr Pulmonol 2009;44:1207-15.
42. Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 2010;16:853-5.
43. Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM et al. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 2010;92:603-11.
44. Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam Horm 2011;86:307-25.
45. Khoo AL, Chai LY, Koenen HJ, Oosting M, Steinmeyer A, Zuegel U et al. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011;55:294-300.
46. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007;86:714-7. (Pubitemid 47435839)
47. Leow L, Simpson T, Cursons R, Karalus N, Hancox RJ. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011;16:611-6.
48. Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M et al.; for the EuroSIDA Study Group. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011;25:1305-15.
49. Campbell GR, Spector SA. Hormonally active vitamin D3 (1{alpha},25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011;286:18890-902.
50. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-dydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.
51. Belderbos ME, Houben ML, Wilbrink B, Lentjes E, Bloemen EM, Kimpen JLL et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011;127:e1513-20.
52. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993,91:2552-5. (Pubitemid 23182508)
53. Lu Z, Chen T, Zhang A, Persons K, Kohn N, Berkowitz R et al. An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D.J Ster Biochem Mol Biol 2007;103:642-4. (Pubitemid 46420520)
54. Berwick M. Can UV exposure reduce mortality? Cancer Epidemiol Biomarkers Prev 2011;20:582-4.
55. Yang L, Lof M, Veierød MB, Sandin S, Adami HO, Weiderpass E. Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev 2011;20:683-90.
56. Anderson LN, Cotterchio M, Kirsh VA, Knight JA. Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: A populationbased case-control study among Ontario women. Am J Epidemiol 2011;174:293-304.
57. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in U.S. and Europe. BMJ 2010;340:b5463.
58. Nurmi-Lüthje I, Sund R, Juntunen M, Lüthje P. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and anti-osteoporotic drugs are associated with lower mortality. A nationwide study in Finland. J Bone Miner Res 2011;26:1845-53.
59. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7. (Pubitemid 47403059)
60. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-23.
61. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91. (Pubitemid 46890428)
62. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009;27:3757-63.
63. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2009;2:598-604.
64. Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 2011;94:534-42.
65. Shieh A, Carmel A, Bockman R et at. Vitamin D insufficiency is associated with decreased bisphosphonate response. ENDO 2011; Abstract P1-228. The Endocrine Society, Boston 4-7 June 2011.
66. VITAL Study. [cited 2011 Jul 7]. Available from: http://www.vitalstudy. org/.
67. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr 2006;136:887-92.
68. Kogawa M, Findlay DM, Anderson PH, Ormsby R, Vincent C, Morris HA et al. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology 2010;151:4613-25.
69. Lou YR, Molnár F, Peräkylä M, Qiao S, Kalueff AV, St-Arnaud R et al. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2010;118:162-70.